Healthcare · Vaccine antigens production
Japan produces no vaccine antigens on an industrial scale — the figure stands at 30 million doses million doses in 2026. This stems from a historic shift: after several high-profile adverse events in the 1990s, Japan tightened vaccine regulations dramatically, opting to import finished products from Europe and the US. Instead of antigen production, Japan focuses on developing innovative adjuvants and delivery systems, where it leads globally. The country ranks 9th out of 197 worldwide.
Data for 2026 · unit: million doses
Position
#9 / 197
Japan world ranking
Country position on the scale from last to first place for this indicator.
JP
#9
#197#1
Trend
Change over time
Change in indicator over the available period.
1
1950
5
1990
2
2000
30
2010
50
2020
30
2025
30
2026
Values — million doses
Comparison
Top countries by Vaccine antigens production
Where Japan stands in the world ranking.
1
CNChina
5 K
2
USUSA
500
3
BRBrazil
400
4
FRFrance
160
5
INIndia
100
5
RURussia
100
7
CACanada
60
8
AUAustralia
50
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Vaccine antigens production in Japan — how much?
Based on 2026 data — 30 million doses. This is rank #9 out of 197 countries.
What is Japan's rank by Vaccine antigens production?
Japan ranks #9 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Japan?
Over the available period the indicator changed from 1 to 30 million doses.